Cargando…
PB2019: PHASE 1B CLINICAL STUDY OF IRAK 1/4 INHIBITION FOR LOW-RISK MYELODYSPLASTIC SYNDROMES REFRACTORY/RESISTANT TO PRIOR THERAPIES: A TRIAL IN PROGRESS
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430302/ http://dx.doi.org/10.1097/01.HS9.0000974884.91552.90 |
| _version_ | 1785090930542379008 |
|---|---|
| author | Garcia-Manero, Guillermo Silverman, Lewis Yan, Lucy Dummer, Wolfgang |
| author_facet | Garcia-Manero, Guillermo Silverman, Lewis Yan, Lucy Dummer, Wolfgang |
| author_sort | Garcia-Manero, Guillermo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430302 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104303022023-08-17 PB2019: PHASE 1B CLINICAL STUDY OF IRAK 1/4 INHIBITION FOR LOW-RISK MYELODYSPLASTIC SYNDROMES REFRACTORY/RESISTANT TO PRIOR THERAPIES: A TRIAL IN PROGRESS Garcia-Manero, Guillermo Silverman, Lewis Yan, Lucy Dummer, Wolfgang Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430302/ http://dx.doi.org/10.1097/01.HS9.0000974884.91552.90 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Garcia-Manero, Guillermo Silverman, Lewis Yan, Lucy Dummer, Wolfgang PB2019: PHASE 1B CLINICAL STUDY OF IRAK 1/4 INHIBITION FOR LOW-RISK MYELODYSPLASTIC SYNDROMES REFRACTORY/RESISTANT TO PRIOR THERAPIES: A TRIAL IN PROGRESS |
| title | PB2019: PHASE 1B CLINICAL STUDY OF IRAK 1/4 INHIBITION FOR LOW-RISK MYELODYSPLASTIC SYNDROMES REFRACTORY/RESISTANT TO PRIOR THERAPIES: A TRIAL IN PROGRESS |
| title_full | PB2019: PHASE 1B CLINICAL STUDY OF IRAK 1/4 INHIBITION FOR LOW-RISK MYELODYSPLASTIC SYNDROMES REFRACTORY/RESISTANT TO PRIOR THERAPIES: A TRIAL IN PROGRESS |
| title_fullStr | PB2019: PHASE 1B CLINICAL STUDY OF IRAK 1/4 INHIBITION FOR LOW-RISK MYELODYSPLASTIC SYNDROMES REFRACTORY/RESISTANT TO PRIOR THERAPIES: A TRIAL IN PROGRESS |
| title_full_unstemmed | PB2019: PHASE 1B CLINICAL STUDY OF IRAK 1/4 INHIBITION FOR LOW-RISK MYELODYSPLASTIC SYNDROMES REFRACTORY/RESISTANT TO PRIOR THERAPIES: A TRIAL IN PROGRESS |
| title_short | PB2019: PHASE 1B CLINICAL STUDY OF IRAK 1/4 INHIBITION FOR LOW-RISK MYELODYSPLASTIC SYNDROMES REFRACTORY/RESISTANT TO PRIOR THERAPIES: A TRIAL IN PROGRESS |
| title_sort | pb2019: phase 1b clinical study of irak 1/4 inhibition for low-risk myelodysplastic syndromes refractory/resistant to prior therapies: a trial in progress |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430302/ http://dx.doi.org/10.1097/01.HS9.0000974884.91552.90 |
| work_keys_str_mv | AT garciamaneroguillermo pb2019phase1bclinicalstudyofirak14inhibitionforlowriskmyelodysplasticsyndromesrefractoryresistanttopriortherapiesatrialinprogress AT silvermanlewis pb2019phase1bclinicalstudyofirak14inhibitionforlowriskmyelodysplasticsyndromesrefractoryresistanttopriortherapiesatrialinprogress AT yanlucy pb2019phase1bclinicalstudyofirak14inhibitionforlowriskmyelodysplasticsyndromesrefractoryresistanttopriortherapiesatrialinprogress AT dummerwolfgang pb2019phase1bclinicalstudyofirak14inhibitionforlowriskmyelodysplasticsyndromesrefractoryresistanttopriortherapiesatrialinprogress |